Loading compound...
Beta-secretase 1 inhibitor
ELENBECESTAT (also known as E-2609 or E26) is a small molecule drug currently being studied in clinical trials. It works as a beta-secretase 1 inhibitor, which is a mechanism being researched for the treatment of Alzheimer disease.
How it worksIt works by inhibiting beta-secretase 1.
Used for
Alzheimer disease
Conditions
Alzheimer disease
Class
Beta-secretase 1 inhibitorNervous system
How to take
This drug is currently in Phase 3 clinical trials and is not yet FDA-approved for general use.
Talk to your doctor
Questions to ask
- ·Is ELENBECESTAT part of a clinical trial I can join?
- ·How does a beta-secretase 1 inhibitor work for Alzheimer's?
Educational summary derived from FDA labeling, AI-assisted. Not medical advice — consult a healthcare professional. Updated 2026-04-25.
